Strategic initiatives by market players will support Germany COVID-19 Diagnostics Market in 2020

Germany COVID-19 diagnostics industry will see the considerable decline of 29.6% during the forecast period. A significant trend in the number of tests conducted in laboratories has been reported in the country. On June 03, 2020, Germany adopted its second economic-stimulus package since the start of the COVID-19 pandemic, which brings total support to $1.5 trillion, which is by far the largest in Europe as a share of GDP. This will support the economy to fight against the COVID-19 pandemic. Moreover, as a result of the faster spread of COVID-19 in the country, the companies are significantly focusing on launching new accurate, faster, and reliable diagnostic platforms for COVID-19 testing. Some of the instance of new diagnostic test & technology includes:

• On July 03, 2020, German scientists began a nationwide study to gain a better overview of the actual prevalence of the new coronavirus in the country’s population and test how well measures to prevent its spread are working. The study by the Helmholtz Center for Infection Research (HZI) will start by testing around 3,000 blood samples from residents in the southern German town of Reutlingen for antibodies created when the immune system fights the coronavirus.  Scientists will conduct five different antibody tests on each sample. The study will take place over a period of one year, with additional blood samples being collected and tested again in selected districts across Germany four and eight months after the first survey. Antibody studies, also known as seroprevalence research, are considered critical to understanding where an outbreak is spreading and can help guide decisions on restrictions needed to contain it.
• On April 21, 2020, Germany declared that it is carrying out Europe’s first large-scale coronavirus antibody testing to support assess infection rates and monitor the spread of the virus. Authorities say they will examine about 5,000 blood samples every 14 days, while regions like Bavaria plan to collect around 3,000 samples from representatively selected households.

Browse the full report description Germany COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-User (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026 at https://www.omrglobal.com/industry-reports/germany-covid-19-diagnostics-market

Market Coverage

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment dominates the market in base year?
• Which segment will project fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?

o Recovery Timeline

o Deviation from pre-COVID-19 

o Most affected segment

o Recommendations 

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Germany COVID-19 Diagnostics Market – Segmentation

By Type

• Instruments
• Reagents & Kits
• Laboratory Testing Services

By Technology Type

• PCR Test
• Antigen Test

o Chromatographic Immunoassay

o Fluorescent Immunoassay

o Chemiluminescent Immunoassay

• Serology Test

o Enzyme-Linked Immunosorbent Assay (ELISA)

o Neutralization

o Chemiluminescent Immunoassay

• Rapid/ PoC Test

By Sample Type

• Oropharyngeal & Nasopharyngeal Swabs
• Blood
• Urine
• Saliva
• Others (Sperm)

By End-Users

• Laboratories
• Hospitals
• Diagnostic Centers & Clinics
• Research Institutes